ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more
Market Cap & Net Worth: ACOTEC SCIEN.H. DL-00001 (7W3)
ACOTEC SCIEN.H. DL-00001 (F:7W3) has a market capitalization of $395.67 Million (€385.47 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #20235 globally and #2168 in its home market, demonstrating a 1.65% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ACOTEC SCIEN.H. DL-00001's stock price €1.23 by its total outstanding shares 313389171 (313.39 Million).
ACOTEC SCIEN.H. DL-00001 Market Cap History: 2021 to 2026
ACOTEC SCIEN.H. DL-00001's market capitalization history from 2021 to 2026. Data shows change from $386.02 Million to $395.67 Million (-9.46% CAGR).
ACOTEC SCIEN.H. DL-00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ACOTEC SCIEN.H. DL-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7W3 by Market Capitalization
Companies near ACOTEC SCIEN.H. DL-00001 in the global market cap rankings as of March 19, 2026.
Key companies related to ACOTEC SCIEN.H. DL-00001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
ACOTEC SCIEN.H. DL-00001 Historical Marketcap From 2021 to 2026
Between 2021 and today, ACOTEC SCIEN.H. DL-00001's market cap moved from $386.02 Million to $ 395.67 Million, with a yearly change of -9.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €395.67 Million | -13.99% |
| 2025 | €460.01 Million | +97.24% |
| 2024 | €233.22 Million | -41.06% |
| 2023 | €395.67 Million | -38.50% |
| 2022 | €643.37 Million | +66.67% |
| 2021 | €386.02 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ACOTEC SCIEN.H. DL-00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $395.67 Million USD |
| MoneyControl | $395.67 Million USD |
| MarketWatch | $395.67 Million USD |
| marketcap.company | $395.67 Million USD |
| Reuters | $395.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.